Literature DB >> 18216119

Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp.

Charles M Chau1, Zhong Deng, Hyojueng Kang, Paul M Lieberman.   

Abstract

The Epstein-Barr virus C promoter (Cp) regulates the major multicistronic transcript encoding the EBNA-LP, 1, 2, and 3 genes required for B-cell proliferation during latency. The growth-transforming potential of these viral genes suggests that they must be tightly regulated with the host cell cycle and differentiation process. To better understand Cp regulation, we used DNA affinity purification to identify cellular and viral proteins that bind to Cp in latently infected cells. Several previously unknown factors were identified, including the cell cycle regulatory proteins E2F1 and Rb. E2F1 bound to a specific site in Cp located in the core Cp region 3' of the known EBNA2-responsive RBP-Jk (CSL, CBF1) binding site. The histone H3 K4 demethylase LSD1 (BCC110) was also identified by DNA affinity and was shown to form a stable complex with Rb. Coimmunoprecipitation assays demonstrated that E2F1, Rb, and LSD1 bind to Cp in a cell cycle-dependent manner. Rb and LSD1 binding to Cp increased after the S phase, corresponding to a decrease in histone H3 K4 methylation and Cp transcription. Coimmunoprecipitation and immunofluorescence assays reveal that LSD1 interacts with Rb. Surprisingly, LSD1 did not coimmunoprecipitate with E2F1, suggesting that it associates with Rb independently of E2F1. Depletion of LSD1 by small interfering RNAs inhibited Cp basal transcription levels, and overexpression of LSD1 altered the cell cycle profile in p53-positive (p53(+)), but not p53-negative (p53(-)), HCT cells. These findings indicate that Cp is a cell cycle-regulated promoter that is under the control of Rb and the histone demethylase LSD1 in multiple latency types.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216119      PMCID: PMC2268494          DOI: 10.1128/JVI.01412-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process.

Authors:  Federico Forneris; Claudia Binda; Maria Antonietta Vanoni; Andrea Mattevi; Elena Battaglioli
Journal:  FEBS Lett       Date:  2005-04-11       Impact factor: 4.124

3.  A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.

Authors:  B Zhao; D R Marshall; C E Sample
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 4.  Transcriptional control of the cell cycle.

Authors:  I Sánchez; B D Dynlacht
Journal:  Curr Opin Cell Biol       Date:  1996-06       Impact factor: 8.382

5.  Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.

Authors:  E M Fuentes-Pananá; P D Ling
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Retinoblastoma protein recruits histone deacetylase to repress transcription.

Authors:  A Brehm; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

7.  The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).

Authors:  E S Robertson; J Lin; E Kieff
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 8.  Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

Authors:  S H Speck; T Chatila; E Flemington
Journal:  Trends Microbiol       Date:  1997-10       Impact factor: 17.079

9.  Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.

Authors:  C Nonkwelo; I K Ruf; J Sample
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

10.  Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Authors:  J J Hsieh; S D Hayward
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

View more
  18 in total

1.  The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro.

Authors:  Feng-Wei Wang; Xian-Rui Wu; Wen-Ju Liu; Ying-Jie Liang; Yu-Fan Huang; Yi-Ji Liao; Chun-Kui Shao; Yong-Sheng Zong; Shi-Juan Mai; Dan Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-07       Impact factor: 2.503

2.  HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.

Authors:  Jiangfang Wang; Emma L Reuschel; Jason M Shackelford; Lauren Jeang; Debra K Shivers; J Alan Diehl; Xiao-Fang Yu; Terri H Finkel
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

Review 3.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

4.  The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.

Authors:  Rosemary J Tierney; Jasdeep Nagra; Martin Rowe; Andrew I Bell; Alan B Rickinson
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

5.  Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

Authors:  Savita Sankar; Emily R Theisen; Jared Bearss; Timothy Mulvihill; Laura M Hoffman; Venkataswamy Sorna; Mary C Beckerle; Sunil Sharma; Stephen L Lessnick
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

Review 6.  Chromatin organization of gammaherpesvirus latent genomes.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Biochim Biophys Acta       Date:  2009-10-22

7.  LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.

Authors:  Y He; Y Zhao; L Wang; L R Bohrer; Y Pan; L Wang; H Huang
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

Review 8.  Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation.

Authors:  M K Kang; S Mehrazarin; N-H Park; C-Y Wang
Journal:  Oral Dis       Date:  2016-09-15       Impact factor: 3.511

9.  microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1.

Authors:  Junbo Rong; Zhigang Li; Limin Xu; Lijuan Lang; Guangying Zheng
Journal:  Cell Cycle       Date:  2021-01-21       Impact factor: 4.534

10.  NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations.

Authors:  Raffaella Gatta; Roberto Mantovani
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.